Hong Yuan Holding Group
HGYN - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.91M
Close$
$0.06
107.7% upside
Current Fair Value
107.7% upsideUndervalued by 107.7% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $2.91 Million |
|---|---|
| Enterprise Value | $3.00 Million |
| Earnings per Share | $0 |
| Beta | 3.7 |
| Outstanding Shares | 74,640,766 |
Return
| Return on Equity | 44.30% |
|---|---|
| Return on Assets | -16.02% |
| Return on Invested Capital | 63.68% |
Valuation & Multiples
| P/E Ratio | -27.86 |
|---|---|
| PEG | 6.65 |
| Price to Sales | - |
| Price to Book Ratio | -0.03 |
| Enterprise Value to Revenue | 5.35 |
| Enterprise Value to EBIT | -32.62 |
| Enterprise Value to Net Income | -30 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | -0.43 |
Revenue Sources
No data
Last Earnings Call
Report Date
September 18, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Hong Yuan Holding Group
10 employees
CEO: Xudong Li
Hong Yuan Holding Group presently conducts no substantial business operations. Historically, the company's primary focus lay in the advancement and commercialization of bio-derived resins. It operated under the name Cereplast, Inc. until...